Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-12-000004

CEO bought 20,000 shares at $0.68 ($13,600)

From the SEC's structured data for this filing

Trades in this filing

Babcock Dwight William · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2011-12-20 Purchase : show line 1 in the form +9,974 $0.68 $6,782 175,847 D
2011-12-21 Purchase : show line 2 in the form +10,026 $0.68 $6,818 185,873 D
Open-market purchases · 20,000 sh · avg $0.68 · $13,600
Loading xslF345X03/primary_doc.xml…